Invictus MD (CSE:IMH, OTC:IVITF) reports that Future Harvest Development Ltd. (of which Invictus MD currently owns 82.5%) has generated $1.578 million in revenue.
Cannabis News
Tokyo Smoke partners with ex-CEO and ex-Creative Director of Canopy Growth Corp. to form Nesta Brand Co.
Tokyo Smoke has partnered with cannabis business visionaries Chuck Rifici (co-founder and ex-CEO of Canopy Growth [formerly Tweed]) and Ian Rapsey (formerly Creative Director of Tweed, The Greater Good Collective and Bruce Mau Design) of Nesta Holding Co, a cannabis-focused private equity firm to form Nesta Brand Co.
Organigram Recall is a Huge Opportunity for Investors
Organigram (TSX.V:OGI, OTCQB:OGRMF) began a voluntary recall of a total of 74 products produced between February 1 and December 16, 2016. These lots tested positive for two pesticides that aren't authorized for use on cannabis plants under the Pest Control Products Act but there are long-term benefits for the recall.
Invictus MD Inc. Aquiring Canadian Companies in Preparation of Canadian Legalization
Invictus MD Strategies Inc. (CSE:IMH,OTC:IVITF) has a flurry of recent developments as the company builds a portfolio of Canadian licensed producers preparing to move into the recreational market.
The Canadian Bioceutical Corp. Signs up Market Maker
The Canadian Bioceutical Corporation (CSE:BCC,OTC:CBICF) announces that it has entered into a Market Making Services Agreement with Venture Liquidity Providers Inc. for an initial 12 month term.
AusCann (OTCPK:ACNNF) Set To Lead The Australian Marijuana Market
AusCann recently went public via a reverse takeover on the ASX. Their joint-venture with Daya Foundation in Chile and Canopy Growth in Canada puts them at the head of the pack in the Australian market. Canopy Growth Corporation will potentially make the move to buy AusCann.
Organigram Inc., (CVE:OGI, OTC:OGRMF) Appoints New CEO
Organigram Inc., which was discovered selling products containing a banned pesticide announces that Greg Engel has been appointed CEO, taking over from Denis Arsenault.
“Greater Enforcement” of Federal Laws would have Mixed Impact in Cannabis Industry
The White House struck a chord with the marijuana industry last week when press secretary Sean Spicer said the Department of Justice is likely to enforce federal marijuana laws in states that have legalized recreational pot.
Singlepoint, Inc. (SING) Forecasts Growth through Acquisitions, Joint Ventures in 2017
Singlepoint’s (OTC: SING) founder, president and CEO Greg Lambrecht recently gave an interview on Money TV with Donald Baillargeon, discussing the company’s acquisition strategy and recent stock performance.
The Tangential Opportunities of the Cannabis Industry
The cannabis industry is heating up. More than half of the 50 states in the U.S. have now legalized marijuana for medicinal or recreational use, and several countries, including Brazil, Canada, Jamaica, Mexico, Paraguay, Portugal, Uruguay and the Netherlands, have also taken steps to legalize or decriminalize cannabis in the last two years.
Recall on Plants Containing myclobutanil Pesticide in Canada
When heated, myclobutanil is known to create hydrogen cyanide which is extremely poisonous. 3 of the 38 federally licensed marijuana growing companies have had to recall their products due to the presence of the myclobutanil pesticide.
Aurora Cannabis Inc. Heading to Become #1
Aurora Cannabis Inc. (TSXV:ACB) is a high-flying Canadian medical marijuana producer that is slowly creeping up on Canopy Growth Corp. (TSX:WEED) and Aphria Inc. (TSXV:APH). The company has a $787 million market cap, but it could soon break the $1 billion mark later this year.
Colorado to Become First State with Licensed Cannabis Clubs
Colorado is on the brink of becoming the first state with licensed pot clubs. But the details of how these clubs will operate are as hazy as the underground clubs operating already.
Emerald Health Therapeutics Inc. (TSX.V:EMH) Projects Annual Sales of $50million
It's a race to riches that has just begun among a handful of Canada’s licensed, industrial-scale medical marijuana growers – each of whom wants to capitalize on in-house IP that can turn cannabis into mainstream medicine. In the quest to find the next GW, Dundee Capital Markets is championing Emerald Heath Therapeutics Inc.
Courtagen Launches New Avantra Genetics Division
Courtagen Life Sciences, Inc., has launched Avantra Genetics. Avantra is dedicated to providing advanced genomic information for functional medicine practices. Patients suffering from functional disorders may experience symptoms such as pain, fatigue, numbness or sensations and gastrointestinal distress that can be severe, chronic or debilitating.